Pediatric Radiology

, Volume 46, Issue 9, pp 1309–1316 | Cite as

Lesional perfusion abnormalities in Leigh disease demonstrated by arterial spin labeling correlate with disease activity

  • Matthew T. Whitehead
  • Bonmyong Lee
  • Andrea Gropman
Original Article

Abstract

Background

Leigh disease is a metabolic disorder of the mitochondrial respiratory chain culminating in symmetrical necrotizing lesions in the deep gray nuclei or brainstem. Apart from classic gliotic/necrotic lesions, small-vessel proliferation is also characteristic on histopathology. We have observed lesional hyperperfusion on arterial spin-labeling (ASL) sequence in children with Leigh disease.

Objective

In this cross-sectional analysis, we evaluated lesional ASL perfusion characteristics in children with Leigh syndrome.

Materials and methods

We searched the imaging database from an academic children’s hospital for “arterial spin labeling, perfusion, necrosis, lactate, and Leigh” to build a cohort of children for retrospective analysis. We reviewed each child’s medical record to confirm a diagnosis of Leigh disease, excluding exams with artifact, technical limitations, and without ASL images. We evaluated the degree and extent of cerebral blood flow and relationship to brain lesions. Images were compared to normal exams from an aged-matche cohort.

Results

The database search yielded 45 exams; 30 were excluded. We evaluated 15 exams from 8 children with Leigh disease and 15 age-matched normal exams. In general, Leigh brain perfusion ranged from hyperintense (n=10) to hypointense (n=5). Necrotic lesions appeared hypointense/hypoperfused. Active lesions with associated restricted diffusion demonstrated hyperperfusion. ASL perfusion patterns differed significantly from those on age-matched normal studies (P=<.0001). Disease activity positively correlated with cerebral deep gray nuclei hyperperfusion (P=0.0037) and lesion grade (P=0.0256).

Conclusion

Children with Leigh disease have abnormal perfusion of brain lesions. Hyperperfusion can be found in active brain lesions, possibly associated with small-vessel proliferation characteristic of the disease.

Keywords

Arterial spin labeling Children Leigh disease Magnetic resonance imaging Metabolic disease Perfusion 

Notes

Compliance with ethical standards

Conflicts of interest

None

References

  1. 1.
    Ruhoy IS, Saneto RP (2014) The genetics of Leigh syndrome and its implications for clinical practice and risk management. Appl Clin Genet 7:221–234PubMedPubMedCentralGoogle Scholar
  2. 2.
    Rahman S, Blok RD, Dahl HH et al (1996) Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39:343–351CrossRefPubMedGoogle Scholar
  3. 3.
    Parikh S, Goldstein A, Koenig MK et al (2015) Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med 17:689–701CrossRefPubMedGoogle Scholar
  4. 4.
    Arii J, Tanabe Y (2000) Leigh syndrome: serial MR imaging and clinical follow-up. AJNR Am J Neuroradiol 21:1502–1509PubMedGoogle Scholar
  5. 5.
    Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216–221CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Lake NJ, Bird MJ, Isohanni P, Paetau A (2015) Leigh syndrome: neuropathology and pathogenesis 74:482–492Google Scholar
  7. 7.
    Alsop DC, Detre JA, Golay X et al (2015) Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL dementia. Magn Reson Med 73:102–116CrossRefPubMedGoogle Scholar
  8. 8.
    Wintermark M, Lepori D, Cotting J et al (2004) Brain perfusion in children: evolution with age assessed by quantitative perfusion computed tomography. Pediatrics 113:1642–1652CrossRefPubMedGoogle Scholar
  9. 9.
    Gropman AL (2013) Mitochondrial mechanisms and neurological disorders. Neurotherapeutics 10:185CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Gropman AL (2013) Neuroimaging in mitochondrial disorders. Neurotherapeutics 10:273–285CrossRefPubMedGoogle Scholar
  11. 11.
    Takahashi S, Oki J, Miyamoto A et al (1999) Proton magnetic resonance spectroscopy to study the metabolic changes in the brain of a patient with Leigh syndrome. Brain Dev 21:200–204CrossRefPubMedGoogle Scholar
  12. 12.
    Krageloh-Mann I, Grodd W, Schoning M et al (1993) Proton spectroscopy in five patients with Leigh’s disease and mitochondrial enzyme deficiency. Dev Med Child Neurol 35:769–776CrossRefPubMedGoogle Scholar
  13. 13.
    Jurkiewicz E, Chelstowska S, Pakula-Kosciesza I et al (2011) Proton MR spectroscopy in patients with Leigh syndrome. Neuroradiol J 24:424–428CrossRefPubMedGoogle Scholar
  14. 14.
    Barkovich AJ, Patay Z (2012) Metabolic, toxic, and inflammatory brain disorders. In: Barkovich AJ, Raybaud C (eds) Pediatric neuroimaging, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 178–182Google Scholar
  15. 15.
    Delonlay P, Rotig A, Sarnat HB (2013) Respiratory chain deficiencies. Handb Clin Neurol 113:1651–1666CrossRefPubMedGoogle Scholar
  16. 16.
    Whitehead MT, Fricke S, Gropman A (2015) Structural brain defects. Clin Perinatol 242:337–361CrossRefGoogle Scholar
  17. 17.
    Hegde AN, Mohan S, Lath N et al (2011) Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus. Radiographics 31:5–30CrossRefPubMedGoogle Scholar
  18. 18.
    Deibler AD, Pollock JM, Kraft RA et al (2008) Arterial spin-labeling in routine clinical practice, part 1: techniques and artifacts. AJNR Am J Neuroradiol 29:1228–1234CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Deibler AR, Pollock JM, Kraft RA et al (2008) Arterial spin-labeling in routine clinical practice, part 2: hypoperfusion patterns. AJNR Am J Neuroradiol 29:1235–1241CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Deibler AR, Pollock JM, Kraft RA et al (2008) Arterial spin-labeling in routine clinical practice, part 3: hyperperfusion patterns. AJNR Am J Neuroradiol 29:1428–1435CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    László A, Ambrus E, Vörös E et al (2009) 99-mTc-HMPAO single photon emission computed tomography examinations in genetically determined neurometabolic disorders. Ideggyogy Sz 62:168–177PubMedGoogle Scholar
  22. 22.
    Yen TC, Yeh SH (1995) 99mTc-HMPAO brain single photon emission computerized tomography in mitochondrial encephalomyopathies. Zhongua Yi Xue Za Zhi 56:287–291Google Scholar
  23. 23.
    Chen Z, Li J, Lou X et al (2012) Sequential evaluation of brain lesions using functional magnetic resonance imaging in patients with Leigh syndrome. Nan Fang Yi Ke Da Xue Xue Bao 32:1474–1477PubMedGoogle Scholar
  24. 24.
    Chi CS, Lee HF, Tsai CR et al (2011) Lactate peak on brain MRS in children with syndromic mitochondrial diseases. J Chin Med Assoc 74:305–359CrossRefPubMedGoogle Scholar
  25. 25.
    Sijens PE, Smit GP, Rodiger LA et al (2008) MR spectroscopy of the brain in Leigh syndrome. Brain Dev 30:579–583CrossRefPubMedGoogle Scholar
  26. 26.
    Detre JA, Wang ZY, Bogdan AR et al (1991) Regional variation in brain lactate in Leigh syndrome by localized 1H magnetic resonance spectroscopy. Ann Neurol 29:218–221CrossRefPubMedGoogle Scholar
  27. 27.
    Avula S, Parikh S, Demarest S et al (2014) Treatment of mitochondrial disorders. Curr Treat Options Neurol 16:292CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Todd MM, Weeks J (1996) Comparative effects of propofol, pentobarbital, and isoflurane on cerebral blood flow and blood volume. J Neurosurg Anesthesiol 8:296–303CrossRefPubMedGoogle Scholar
  29. 29.
    Wang J, Licht DJ, Jahng GH et al (2003) Pediatric perfusion imaging using pulsed arterial spin labeling. J Magn Reson Imaging 18:404–413CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Matthew T. Whitehead
    • 1
    • 2
  • Bonmyong Lee
    • 3
  • Andrea Gropman
    • 2
    • 4
  1. 1.Department of RadiologyChildren’s National Medical CenterWashingtonUSA
  2. 2.The George Washington University School of MedicineWashingtonUSA
  3. 3.Department of RadiologyThe Johns Hopkins Medical InstituteBaltimoreUSA
  4. 4.Department of NeurologyChildren’s National Medical CenterWashingtonUSA

Personalised recommendations